Aldeyra Therapeutics's total assets for Q4 2024 were $104.61M, a decrease of -10.84% from the previous quarter. DE:137 total liabilities were $33.60M for the fiscal quarter, a 4.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.